Scintigraphic assessment of SO dysfunction
As diagnosis of sphincter of Oddi (SO) dysfunction may require perendoscopic manometric assessment of the sphincter, which is an invasive technique carrying a significant risk of pancreatitis, non-invasive scintigraphy has been proposed as an alternative diagnostic method. Craig et al (Gut 2003;52:352-7) reported their experience in assessing SO dysfunction in post-cholecystectomy patients with scintigraphy using the hepatic hilum-duodenum transit time (HHDT) of Cicala and colleagues 1 and the scoring system of Sostre and colleagues. 2 In the study of Craig et al, scintigraphic data after cholecystokinin octapeptide (CCK-OP) infusion were compared with SO basal pressure, the latter recorded at manometry in the absence of any stimulus.
Craig et al concluded that none of the above scintigraphic variables was sufficiently sensitive to diagnose SO dysfunction identified at SO manometry. Although it is evident that the scintigraphic method of Craig et al used in their study was indeed poorly sensitive, the conclusion of their study cannot be extended to interpret the validity of scintigraphy, as performed in other centres.
It is necessary to identify regions of interest (ROIs) that are repeatable. In the original description of the method it was pointed out that only HHDT performed with the correct ROIs and subtractions was repeatable, compared with other scintigraphic variables related to hepatic uptake and clearance of radiolabelled bile. 1 Noticeably in the original HHDT method, ROIs were the heart, right external liver parenchyma, hepatic hilum, and duodenum, whereas in Craig's study ROIs were the right lobe of the liver and the common bile duct (CBD), which are not sufficient reference sites to construct a transit measurement from the hepatic hilum to the duodenum. In addition, an ROI placed on the CBD cannot correctly discriminate CBD activity from that of the major bile ducts at the hepatic hilum.
Furthermore, analysis of time threshold performed on visual assessment of three minute composite images implies a measurement error of several minutes. In addition, assessment of radiolabelled bile at different sites cannot be performed correctly with a visual method that is significantly delayed in comparison with assessment based on time activity curves (TAC), provided that frame timing is adequate. For example, this methodological error is clearly described and illustrated in figure 3 of the article by Cicala and colleagues, 1 with the original description of the HHDT method where the time period assessed with static images at 2.5 minutes apart was delayed by 2.5 minutes in comparison with the assessment based on the TAC constructed on 15 second frame timing. Use of a cholecystokinetic stimulus to assess HHDT is also questionable as CCK is known to affect hepatic bile secretion and SO motor activity, either accelerating the transit of bile under normal conditions or slowing it in the case of SO paradoxical response. Madacsy and colleagues, 3 comparing measurement of HHDT without any stimulus and after caerulein administration, showed that the 89% sensitivity of the test without the cholecystokinetic stimulus decreased to 0% after the cholecystokinetic stimulus. In addition, it is not acceptable to derive any conclusions on test sensitivity from a comparison between a scintigraphic assessment performed after a cholecystokinetic stimulus and manometric recordings performed in the absence of a stimulus. Craig et al's study refers to .9 minutes as an abnormal threshold of HHDT, as indicated in the study of Cicala and colleagues. 1 Use of a reference threshold from another centre does not apply when a different technique is used. The technique of Craig et al should be validated with correct reference standards defined in a control group, which was lacking in their study.
Several studies have used similar but not comparable scintigraphic techniques to assess SO dysfunction by means of the hepatic duodenum transit time or a score (see table 1 ).
All but one of the studies in ).
Finally, in common with the validation process used for SO manometry, validity of a scintigraphic diagnostic test for SO dysfunction is proved if the tested variable (that is, HHDT or a score) normalises after, and predicts the outcome of, treatment of the abnormality that the test is designed to detect. Both of the above demonstrations for HHDT have been presented in the study by Cicala and colleagues. 4 We are aware that information concerning reliability and outcome prediction of HHDT derive from a single group of investigators and confirmation studies with comparable techniques performed in other centres would be welcome. However, we would caution against making comparisons and drawing conclusions with techniques that are not comparable and have not been submitted to proper validation studies to ascertain their reliability. Proposal for a new histological grading system for posttreatment evaluation of gastric MALT lymphoma
Gastric MALT lymphoma (GML) development is closely associated with Helicobacter pylori infection cases. 1 The majority of stage IE GML regress following H pylori eradication but assessing cure of the disease requires prolonged follow up. Residual lymphoid infiltrate in post-treatment gastric biopsies can be very difficult to interpret and histological criteria for the diagnosis of minimal residual disease or complete remission are not clearly defined. Molecular follow up by polymerase chain reaction (PCR) for the rearranged immunoglobulin heavy chain variable region shows that persistent monoclonal bands is observed in 44% of cases showing apparent complete histological remission. 2 The significance of ongoing PCR monoclonality in the absence of histological disease is still under investigation.
Thus histological evaluation of gastric biopsies remains the cornerstone to assess lymphoma response to therapy. In 1993, Wotherspoon et al proposed a histological scoring system that was initially designated to express the degree of confidence of a diagnosis of GML on gastric biopsies. 3 This histological scoring has been used to evaluate the response to therapy in a number of subsequent trials but many investigators have found the system difficult to apply and of low interobserver reproducibility.
Other studies have used the criteria of partial and complete remission defined by Neubauer and colleagues. 4 Criteria of lymphoma response to therapy need to be standardised using a system that can be easily applied so that results of future clinical trials can be compared.
As part of multicentre clinical trials on GML, GELA (Groupe d'Etude des Lymphomes de l'Adulte) pathologists and one of the authors (ACW) established a posttreatment histological grading system based on evaluation on haematoxylin-eosin (H&E) stained sections of three essential diagnostic features: the lymphoid infiltrate, presence of lymphoepithelial lesions (LEL), and stromal changes. We classified the morphological features observed in post-treatment gastric biopsies as follows: ''complete histological response'' (CR), ''probable minimal residual disease'' (pMRD), ''responding/residual disease'' (rRD), and ''no change'' (NC) (table 1). These groups give clinically relevant information to the clinician. In particular, the category responding/residual disease (rRD) implies that overt lymphoma is present in association with features that suggest a degree of regression. This would imply to the clinician an ongoing response that does not require immediate use of alternative therapies.
To assess the reproducibility of this histological grading system, we selected at random 10 patients with GML enrolled in the GELA clinical trial (seven men and three women; median age 60 years (range 35-74)). 5 A total of 45 sets of gastric biopsies stained with H&E were evaluated separately by each histopathologist blind to the clinical follow up data using the new follow up system. Three to six sequential gastric biopsies were analysed for all patients with a mean follow up of 19 months after H pylori eradication therapy. Interobserver agreement evaluated by the weighted kappa value gave excellent results, with values over 0.84, indicating very good agreement among the seven observers.
Assessing the lymphoma remission status is of great importance for clinical practice. Developing tools to evaluate residual disease are needed, not only for clinical practice but also to conduct clinical trials that aim to define therapeutic guidelines. We propose in this study a histological grading system for the evaluation of post-treatment gastric biopsies. Testing of this scheme in a small number of cases within the group developing this scheme has shown it to be highly reproducible. These results encourage further evaluation of this scheme on larger series, as well as investigation of its clinical significance and impact on clinical guidelines. In combination with molecular studies, this scheme could provide an interesting tool for the evaluation of residual disease in prospective studies on GML.
C Copie-Bergman, P Gaulard Remarkable resemblance in the mode of transmission of HCV infection among haemodialysis patients and IVDAs
Hepatitis C virus (HCV) infection is widespread among patients on long term haemodialysis (HD) and among intravenous drug abusers (IVDAs). However, there appear to be striking similarities in the mode of transmission between the two groups as both are at high risk for parenterally transmitted HCV infection. The indispensable requirement of having a vascular access site possibly adds to the risk of acquiring HCV infection among patients on long term HD through nosocomial transmission, especially in high HCV prevalence units. Preliminary data suggest that among various types of vascular access used for HD, arteriovenous fistula and polytetrafluoroethylene grafts which require extra skilful handling, perhaps play a more significant role in the transmission of HCV than permanent or temporary central venous catheters. 1 Sharing of contaminated dialysis equipment, dialyser reuse, and the physical proximity of an infected patient during HD are additional important factors incriminated in the transmission of HCV in the busy HD unit. 2 Gilli et al reported an outbreak of HCV in an Italian HD unit due to sharing of multidose heparin vials. 3 Another recent study from the USA reported an outbreak of HCV occurring when a multidose saline vial was contaminated with blood from a HCV infected patient in a Florida hospital. 4 Breakdown in the implementation of standard infection control safety measures recommended by the CDC is essentially responsible for the rapid rise in HCV infection among HD patients worldwide.
Likewise, sharing of contaminated equipment (needles and syringes) among IVDAs is also the primary concern attributed to the continuous increase in HCV infection. However, in a recent report from Kolkata, India, 5 dissemination of HCV accelerated, paradoxically from a baseline prevalence rate of 17% in 1996 to 66% in 2002 and to 80% during the next year, regardless of the supply of fresh needles and syringes on a daily basis, under the supervision of trained field workers, with the equipment being taken away from IVDAs on the next day after use. Most of the IVDAs did not share their syringes or needles; none the less, they shared the multidose vials of the drugs. Indirectly sharing of the drug ampoules suggested contaminated body fluids/blood being the means of transmission of HCV through direct access to the blood circulation. Transmission of virus was also suspected to occur from sharing of a small pot containing water that some IVDAs used to clean the syringes and needles before using them again.
With strict implementation of standard infection control precautions and probably isolation of anti-HCV positive patients, it may be possible to effectively control the spread of HCV infection among patients on long term HD. 6 However, promiscuous sexual behaviour, lack of personal and community hygiene, and absolute disregard for life, prevalent among IVDAs, are the major practical problems preventing implementation of interventional measures for the control of the spread of HCV in this high risk group. What will all the technicians do?
However, Dr Neale has perhaps been a little over cautious in condemning colonoscopy in case No 1. I would agree that colonoscopy in case No 2 with a macrocytic anaemia and possible haematemesis must be regarded as a very doubtful indication. However, in case No 1, with a marked microcytic anaemia and recurrent melaena without a definite cause in the upper gastrointestinal tract, many would regard visualisation of the colon by whatever means prudent, although given the likely comorbidity a non-invasive test might have been better, depending on resources. It is clear that in both of these typical cases appropriate thought had not gone into the diagnostic approach but also interestingly that in these days of great service pressures it was possible to perform oesophagogastroduodenoscopy and colonoscopy before haematinic estimations. In both cases the colonoscopist must share the blame for taking an overly technical view; bowel preparation may be rather unpleasant but that is no reason to continue and perform an unnecessary investigation if the patient turns up on a list. I would echo Dr Neale's thoughtful suggestion that we need to concentrate more on efficacy and safety of care.
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Author's reply I thank Dr Beales for his comments. Clearly, it is always easy to be wise in retrospect. However, we teach students to make a diagnosis by listing the positive findings and linking these to build a coherent diagnosis. In case No 1, the house officer noted aspirin ingestion, melaena, a hard liver edge, and thrombocytopenia. He suggested cancer of the gut with hepatic metastases. This was reasonable enough even though it did not include thrombocytopenia.
The next logical step might have been scanning of the upper abdomen in which case splenomegaly would have been added to the list and from there it was only a short step to hepatic cirrhosis and possible reinterpretation of the erythematous/exudative gastritis.
We also teach that patients be told the riskbenefit ratio of any procedure.
1 Frank melaena is a rare presentation of cancer of the colon and the risk of colonoscopy is perhaps 0.2%.
I leave the reader to decide if the present day gastroenterologist should concentrate on honing specialist technical skills to gather information or should develop as a consultant who weighs the evidence as it unfolds. 
G Neale

